These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacy-initiated implementation of a syringe pump infusion system. Goudreau JB; Morrissey JM Am J Hosp Pharm; 1985 Mar; 42(3):584-7. PubMed ID: 3985022 [TBL] [Abstract][Full Text] [Related]
3. Cost of wastage in a hospital intravenous admixture program. Salberg DJ; Newton RW; Leduc DT Hosp Formul; 1984 May; 19(5):375-8. PubMed ID: 10266241 [TBL] [Abstract][Full Text] [Related]
4. Implementation and cost analysis of a syringe pump system for intermittent i.v. drug delivery. Colangelo A; Clark ST; Janousek JP Am J Hosp Pharm; 1985 Mar; 42(3):581-4. PubMed ID: 3985021 [TBL] [Abstract][Full Text] [Related]
5. Cost, motion, and time studies comparing a new cephalosporin admixture system. Turco SJ Hosp Pharm; 1982 Dec; 17(12):653-8. PubMed ID: 10257925 [No Abstract] [Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
7. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment. Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971 [TBL] [Abstract][Full Text] [Related]
8. The use of pharmacy personnel to positively impact hospital finances. Hutchinson RA; Hatoum HT; Kolinski R; Riley DW Hosp Formul; 1989 Aug; 24(8):450, 453. PubMed ID: 10294357 [TBL] [Abstract][Full Text] [Related]
9. IV additive program saves Montreal hospital $300,000. Torchinsky A Health Care (Don Mills); 1986 Jun; 28(5):25-8. PubMed ID: 10277322 [TBL] [Abstract][Full Text] [Related]
10. Cost containment through P & T committee drug utilization review. Bender FH; DeMatteo CS Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of two sterility testing methods for intravenous admixtures. Condella F; Eichelberger K; Foote LC; Griffin RE Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270 [TBL] [Abstract][Full Text] [Related]
13. Cost and time required to add potassium chloride to large-volume parenterals. Turco SJ Hosp Pharm; 1979 Dec; 14(12):718-9. PubMed ID: 10309084 [No Abstract] [Full Text] [Related]
14. Reducing waste: a significant cost containment measure in an i.v. additive program. Coppola PA; Cassidy AP Hosp Pharm; 1987 Dec; 22(12):1215-6, 1246. PubMed ID: 10285376 [TBL] [Abstract][Full Text] [Related]
15. Hospital pharmacy symposium on new concepts in parenteral drug delivery. Anderson RW; Cohen JE; Cohen MR; Kleinberg ML; Lewis GR; McAllister JC; Turco SJ Hosp Pharm; 1986 Nov; 21(11):1033-6, 1043-6, 1052-5. PubMed ID: 10317801 [No Abstract] [Full Text] [Related]
16. A comparison of premixed and non-premixed potassium chloride large-volume parenterals. Turco SJ Hosp Pharm; 1979 Dec; 14(12):720-2. PubMed ID: 10309085 [No Abstract] [Full Text] [Related]
17. Documenting the cost-containment activities of a nutrition support specialist. Rosen GH; Jeffrey PL Curr Concepts Hosp Pharm Manage; 1989; 11(1):4-7. PubMed ID: 10312874 [No Abstract] [Full Text] [Related]
18. Providing financial justification to support a stand-alone computer system in a large tertiary-care hospital. Mahoney CD Curr Concepts Hosp Pharm Manage; 1987; 9(4):7-12. PubMed ID: 10284440 [TBL] [Abstract][Full Text] [Related]
19. A commentary on high-cost drugs. de Leon RF Curr Concepts Hosp Pharm Manage; 1989; 11(3):4-7. PubMed ID: 10318277 [TBL] [Abstract][Full Text] [Related]
20. An in vitro analysis of central venous drug delivery by continuous infusion: the effect of manifold design and port selection. Moss DR; Bartels K; Peterfreund GL; Lovich MA; Sims NM; Peterfreund RA Anesth Analg; 2009 Nov; 109(5):1524-9. PubMed ID: 19843791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]